Prevalence of resistance of Helicobacter pylori strains to selected antibiotics in Isfahan, Iran

Jundishapur Journal of Microbiology

Volumn 6, Issue 5, 2013, Pages

  Mirzaei, Nasrin ^a   Poursina, Farkhondeh ^b   Faghri, Jamshid ^b   Talebi, Majid ^b   Khataminezhad, Mohammad Reza ^a   Hasanzadeh, Akbar ^b   Ghasemian Safaei, Hajieh ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amoxicillin; Clarithromycin; Helicobacter pylori; Metronidazole

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; EPSILOMETER TEST; FEMALE; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEX DIFFERENCE;

HELICOBACTER PYLORI;

EID: 84880825034     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.6342     Document Type: Article

References (45)

1. Jenks PJ, Edwards DI. Metronidazole resistance in Helicobacter pylori. Int J Antimicrob Ag. 2002;19(1):1-7.
2. Sirous M, Mehrabadi JF, Daryani NE, Eshraghi S, Hajikhani S, Shi-razi MH. Prevalence of antimicrobial resistance in Helicobacter pylori isolates from Iran. Afr J Biotech. 2011;9(36):5962-5965.
3. Fallahi GH, Maleknejad S. Helicobacter pylori culture and antimicrobial resistance in Iran. Indian J Pediatrics. 2007;74(2):127-130.
4. Dzierzanowska-Fangrat K, Rozynek E, Celinska-Cedro D, Jarosz M, Pawlowska J, Szadkowski A, et al. Antimicrobial resistance of He-licobacter pylori in Poland: a multicentre study. Int J Antimicrob Agents. 2005;26(3):230-234.
5. Ghasemian Safaei H, Tavakkoli H, Mojtahedi A, Salehei R, Solei-mani B, Pishva E. Correlation of cagA positive Helicobacter pylori Infection with clinical outcomes in Al-zahra hospital, Isfahan, Iran. J Res Med Sci. 2008;13(4):196-201.
6. Kumala W, Rani A. Patterns of Helicobacter pylori isolate resistance to fuoroquinolones, amoxicillin, clarithromycin and metronidazoles. Southeast Asian J Trop Med Public Health. 2006;37(5):970-974.
7. Bahrami AR, Aminipour Harandi MR, Kazemi Kheirabadi E, Shar-ifan B, Hasemian Safaei HG, Rahimi E. Antimicrobial Resistance of Helicobacter pylori Isolates from Cow Feces, Raw Milk and Drinking Water in Iran. Middle East J Sci Res. 2011;10(6):698-701.
8. Hosseini E, Poursina F, Van de Wiele T, Ghasemian Safaei H, Adibi P. Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases. J Res Med Sci. 2012;17(3):280.
9. Ghasemian Safaei H, Havaei SA, Tavakkoli H, Eshaghei M, Nava-bakbar F, Salehei R. Relation of bab A2 genotype of Helicobacter pylori infection with chronic active gastritis, duodenal ulcer and non-cardia active gastritis in Al-zahra hospital Isfahan, Iran. Jundishapur J Microbiol. 2010;3(3):93-98.
10. Hajiani E, Hashemi J, Vosoghi T. Comparision of a 10 day triple and two week quadruple therapy in eradicating Helicobacter pylori infection in patients referred to Imam Khomeini hospital clinics Ahwaz, Iran. Jundishapur J Nat Pharm Prod. 2007;3(1):45-52.
11. Marie MA. Patterns of Helicobacter pylori resistance to metroni-dazole, clarithormycin and amoxicillin in Saudi Arabia. J Bacte-riol Virol. 2008;38(4):173-178.
12. Kim SY, Joo YM, Lee HS, Chung IS, Yoo YJ, Merrell DS, et al. Genetic analysis of Helicobacter pylori clinical isolates suggests resistance to metronidazole can occur without the loss of functional rdxA. J Antibiot (Tokyo). 2009;62(1):43-50.
13. Canton R, Martin de Argila C, De Rafael L, Baquero F. Antimicrobial resistance in Helicobacter pylori. Rev Med Microbiol. 2001;12(1):47.
14. Haghi Tomatari F, Mohabbati Mobarez A, Amini M, Hosseini D, Talebi Bezmin Abadi A. Helicobacter pylori Resistance to Metro-nidazole and Clarithromycin in Dyspeptic Patients in Iran. Iran Red Cres Med J. 2010;12(4):409-412.
15. Siavashi F, Heydarian E, Pourkhajeh AH, Merat sh, Asl soleymani H, Khatibian M, et al. Susceptibility of various strains of Helico-bacter pylori to selected agents. Arch Iran Med. 2000;3(2)
16. Shimoyama T, Fukuda S, Mikami T, Fukushi M, Munakata A. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. J Gastroenterol. 2004;39(10):927-930.
17. Hu CT, Chiou PY, Wu CC, Tseng YH, Chang YJ, Lin NT. Analysis of Resistance to Clarithromycin and Virulence Markers in Helico-bacter pylori Clinical Isolates from Eastern Taiwan. Tzu Chi Med J. 2009;21(2):123-128.
18. Susceptibility testing of Helicobacter pylori. Solna, Sweden: AB Biodisk; 2000.
19. Seck A, Mbengue M, Gassama-Sow A, Diouf L, Ka MM, Boye CS. Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal. J Infect Dev Ctries. 2009;3(2):137-140.
20. Best LM, Haldane DJ, Keelan M, Taylor DE, Thomson AB, Loo V, et al. Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob Agents Chemother. 1977;47(10):3138-3144.
21. British methods for antimicrobial susceptibility testing (BSAC). Version 11. 2012.
22. Farshad S, Alborzi A, Japoni A, Ranjbar R, Hosseini Asl K, Badiee P, et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. World J Gastroen-terol. 2010;16(45):5746-5751.
23. Khashei R, Shojaei H, Adibi P, Shavakhi A, Aslani MM, Daei N. Genetic diversity and drug resistance of Helicobacter pylori strains in Isfahan, Iran. Iran J Basic Med Sci. 2008;11(3):174-182.
24. Kulsuntiwong P, Chomvarin C, Chaicumpar K, Namwat W, Kaewkes W, Mairiang P, et al. Antimicrobial susceptibility of He-licobacter pylori isolated from gastric biopsies in dyspeptic patients. Southeast Asian J Trop Med Public Health. 2008;39(6):1102-1109.
25. Destura RV, Labio ED, Barrett LJ, Alcantara CS, Gloria VI, Daez MLO, et al. Laboratory diagnosis and susceptibility profle of Helico-bacter pylori infection in the Philippines. Ann Clin Microbiol An-timicrob. 2004;3(1):25.
26. Kohanteb J, Bazargani A, Saberi-Firoozi M, Mobasser A. Antimicrobial susceptibility testing of Helicobacter pylori to selected agents by agar dilution method in Shiraz-Iran. Indian J Med Mi-crobiol. 2007;25(4):374-377.
27. Wollek K, Leodolter A, Malfertheiner P, Koenig W. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol. 2002;51(8):705-709.
28. Falsaf T, Mobasheri F, Nariman F, Najaf M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Mi-crobiol. 2004;42(1):387-389.
29. Mohammadi M, Doroud D, Mohajerani N, Massarrat S. Helico-bacter pylori antibiotic resistance in Iran. World J Gastroenterol. 2005;11(38):6009-6013.
30. Siavoshi F, Safari F, Doratotaj D, Khatami GR, Fallahi GH, Mirnas-eri MM. Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children. Arch Iran Med. 2006;9(4):308-314.
31. Mansour B, Burucoa Ch, Zribi M, Masmoudi A, Karoui S, Kallel L, et al. Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob. 2010;9:22-22.
32. Lang L, Garcia F. Comparison of E-test and disk difusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica. Int J Antimicrob Agents. 2004;24(6):572-577.
33. Shokrzadeh L, Jafari F, Dabiri H, Baghaei K, Zojaji H, Alizadeh AH, et al. Antibiotic susceptibility profle of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran. Saudi J Gastro-enterol. 2011;17(4):261-264.
34. Kargar M, Baghernejad M, Doosti A, Ghorbani-Dalini S. Clarithro-mycin resistance and 23S rRNA mutations in Helicobacter pylori isolates in Iran. Afr J Microbiol Res. 2011;5:853-856.
35. Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FA, Osato MS, et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemoth-e r. 2001;47(4):459-461.
36. Ling TK, Leung WK, Lee CC, Ng EK, Yung MY, Chung SS, et al. The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001). Helicobacter. 2002;7(5):327-328.
37. Elviss NC, Owen RJ, Breathnach A, Palmer C, Shetty N. Helico-bacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000. J Med Microbiol. 2005;54(Pt 6):567-574.
38. Ahmad N, Zakaria WR, Abdullah SA, Mohamed R. Characterization of clarithromycin resistance in Malaysian isolates of Helico-bacter pylori. World J Gastroenterol. 2009;15(25):3161-3165.
39. Andrzejewska E, Szkaradkiewicz A, Karpinski T. Antimicrobial resistance of Helicobacter pylori clinical strains in the last 10 years. Pol J Microbiol. 2009;58(4):301-305.
40. Yamade M, Sugimoto M, Uotani T, Nishino M, Kodaira C, Furuta T. Resistance of Helicobacter pylori to quinolones and clarithro-mycin assessed by genetic testing in Japan. J Gastroenterol Hepa-tol. 2011;26(9):1457-1461.
41. Vale FF, Rosa MR, Oleastro M. Helicobacter pylori resistance to antibiotics. Science against microbial pathogens: communicating current research and technological advances. 2011:745-756.
42. Eisig JN, Silva FM, Barbuti RC, Navarro-Rodriguez T, Moraes-Filho JP, Pedrazzoli Jr J. Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option. Arq Gastroenterol. 2011;48(4):261-264.
43. Lofmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50 Suppl 1:S16-S23.
44. Gisbert JP. Rescue Therapy for Helicobacter pylori infection 2012. Gastroenterology res Pract. 2012;2012.
45. Siavoshi F, Saniee P, Latif-Navid S, Massarrat S, Sheykholeslami A. Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies. Arch Iran Med. 2010;13(3):177-187.